In cholangiocarcinoma, Notch 1-3 expression was associated with lower histological differentiation and poorer survival of patients, and combining gemcitabine and GSI-IX prevented gemcitabine-induced enrichment of CSC-like population in in vitro models [584]. The gene discussed is NOTCH1; the disease is cholangiocarcinoma.